Saed Abbasi, Laura Ensign and colleagues at Johns Hopkins University School of Medicine sought to develop an improved platform to deliver mRNA encoding therapeutic proteins specifically to the endometrium to treat reproductive disorders. They chose to use lipid nanoparticles (LNPs) for delivery. While mRNA-LNPs have been used to deliver genes to the placenta before, their performance was limited by off-target expression in other organs.